$BOSQF,...The Yield Growth: Building A Cannabis Lifestyle

New Post Public Reply Private Reply Replies (0) Message Board
nlightn
189
$BOSQF,...The Yield Growth: Building A Cannabis Lifestyle Product Empire-- CFN Media
Wed August 28, 2019

Seattle, Washington--(Newsfile Corp. - August 28, 2019) - CFN Media Group ("CFN Media" , the leading agency and financial media network dedicated to the North American cannabis (USMJ) industry, announces publication of an article covering The Yield Growth (OTCQB: BOSQF) (CSE: BOSS) (FSE: YG3) and its impressive business plan.

47318_580e2713643f38e8_001.jpg

Ayurveda is an ancient medicine system dating back thousands of years in India. In Sanskrit, the word means "The Science of Life." In the simplest sense, it is a holistic approach to healing - including medicating with cannabis - in a harmonious manner with the Earth, including locally sourcing natural ingredients.

For The Yield Growth Corp. (OTCQB: BOSQF) (CSE: BOSS) (FSE: YG3), Ayurveda is integral to business as part of the company's proprietary patent-pending extraction technology combining the ancient therapeutic extraction methods with modern science and commercial hemp root oil for innovative products containing cannabinoids and terpenes. The company has quickly amassed a portfolio of six subsidiaries and global partnerships as it looks to disrupt the $4.2 trillion-dollar global wellness market with a portfolio of premium cannabis-infused consumer goods.


Bigger International Footprint

Yield Growth's flagship brand is Urban Juve, a line of cannabis sativa hemp oil-infused skincare products, including oils, creams, balms and skincare kits, sold throughout the U.S., Canada, China, Japan, South Korea and Germany. Through a new partnership with Melorganics, Greece and Cyprus were added this month to the list of countries where Urban Juve is sold. Per the new pact, Melorganics will act as the exclusive retail distributor and non-exclusive e-commerce distributor for Urban Juve products in Greece and Cyprus.

If it wants to maintain exclusivity in those countries, Melorganics must purchase at least $300,000 worth of Urban Juve products in the first year and $500,000 in each subsequent year. This will add nicely to the $1.98 million that Yield Growth generated in revenue across its portfolio during the first half of 2019.

Lucrative Lip Balm

On Monday, the company said that Urban Juve Lip Balm with Hemp Oil received compliance certification in the European Union, giving the company the green light to move forward with sales initiatives in the bloc. The lip balm, which retails on the Urban Juve website for $9 for a 4-gram stick, is a best selling product for the company.

The certification for the hydrating lip balm comes at a prime time for Urban Juve, as it will be featured in Vogue Beauty Highlights in the October issue of UK Vogue, introducing the product to a new audience of 4.1 million readers.

Also in October, strategic partner and beauty subscription giant ipsy will be including the lip balm in gift bags at the ipsy Live event in New York City.

In preparation for the upcoming exposure, Urban Juve is currently manufacturing 250,000 units of the lip balm for sales throughout all its retail sales and e-commerce outlets. At list price, that represents $2.25 million in sales.


Full Speed Ahead into New Verticals

With hemp legalized throughout the U.S. via the passage of the 2018 Farm Bill in December, high-end spas are increasingly demanding cannabidiol (CBD) products for their therapeutic benefits, which falls right into Yield Growth's wheelhouse. To that end, the company said this month that it is growing vertically by developing a new Ayurveda-inspired CBD-infused Urban Juve Spa Treatment line.

In a bid to tap the $130 billion global gifting market, Urban Juve this month implemented a new service where it offers streamlined gift wrapping and delivery through its e-commerce platform. A particularly unique feature here is Urban Juve's partnership with ParcelPal (PTNYF), which means that customers in select Canadian markets will be able to get their gift-wrapped product the same day, perhaps even within 60 minutes.

Talk about a last-minute birthday, anniversary, Christmas or Valentine's present. The savvy management team doesn't stop with calculated ways to brand and ultimately generate revenue.

Antler Real Men

Elsewhere in August, Yield Growth deepened its relationship with Antler Retail, Inc., the owner of an upstart international clothing and men's grooming products brand called Antler. For starters, an agreement was closed between the two wherein Antler Retail made a payment of $800,000 in its stock for a non-exclusive perpetual license for worldwide rights to eight of Yield Growth's hemp product topical formulas. Using these formulas inspired by Ayurvedic traditions, Antler is developing a new men's line of hair pomade, beard oil, shaving cream, deodorant and four premium essential oil colognes.

Moreover, a distribution agreement was penned between the companies on August 14 giving Yield Growth global distribution rights to the Antler Real Men hemp product line, including the eight new products in the future.

The theme of reciprocity between Yield and Antler to develop innovative products and distribute them globally is underpinned by board members from the companies having serious skin in the game. Penny Green, CEO of Yield Growth and Urban Juve, and Krystal Pineo are directors and significant shareholders at both Yield Growth and Antler, so they clearly are motivated to succeed.


Understanding the New Culture

Yield Growth leadership has seasoned vets with C.V's that include executive positions at the likes of Johnson & Johnson (JNJ), Procter & Gamble, M·A·C Cosmetics, Skechers, Best Buy, Aritzia (ATZAF), Coca-Cola, and Pepsi Corporation. Point being, those steering the ship know a thing or two about building global brands.

As such, the company has retained acclaimed graphic design and branding company The Design Spot and brand and packaging design agency Cornerstone Strategic Branding to assist in these important branding initiatives to build market traction. Furthermore, Yield Growth is staying with the times, utilizing social media campaigns and influencer marketing to spread brands awareness and drive sales, particularly with subsidiary Wright & Well's initial shipment going into the Oregon markets.

These initiatives speak volumes about Yield's mantra of marrying the ancient healthcare modality of Ayurveda with modern technologies for whole body healing that is often synonymous with the emotional and spiritual ways of cannabis consumers. This is owing to a deep understanding of product development and marketing to a diverse audience.

In today's world, products are more associated with lifestyles than ever before. Millennials are a whole new culture of consumer as they actively seek out brands, companies and products that they can identify with, which augurs well for Yield Growth and its lineup of brands.

Click here to receive and investor deck and corporate updates

For more information, visit the company's website at: https://yieldgrowth.com/

https://seekingalpha.com/pr/17615182-yield-gr...-cfn-media
Scroll down for more posts ▼

Top 10 Most Recent News Articles

2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 34

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 39

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 31

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 36

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 45

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 41

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading

Top 5 Most Recently Viewed Articles

Celebrating Green Leaders: 2024 IGIHOF Induction Ceremony Details

Updated Category News Views 276

Celebrating the Newest Inductees into the Green Industry The International Green Industry Hall of Fame (IGIHOF) is gearing up for its annual induction ceremony, where it will honor nine remarkable individuals and organizations dedicated to advancing ecological sustainability. This year, the event will take place within the environment of innovative learning at the...

Continue Reading
Governor Advocates for Controlled Substances Decriminalization

Updated Category News Views 48

Governor Advocates for Controlled Substances Decriminalization Puerto Rico’s Governor Pedro Pierluisi Urrutia has made a compelling argument for decriminalizing the consumption of all controlled substances. His stance primarily addresses the pressing fentanyl crisis affecting communities across the island. Governor Pierluisi highlighted, "I have said since the 90s that...

Continue Reading
Odyssey Marine Exploration: Navigating Stock Market Challenges

Updated Category News Views 221

Recent Trends in Odyssey Marine Exploration Stock Odyssey Marine Exploration, Inc. (NASDAQ: OMEX) has seen its stock price fluctuate significantly in recent times. After an arbitration award involving the company and the United Mexican States was announced, the stock experienced a sharp decline, which has sparked concerns about its future path. Decoding the Arbitration...

Continue Reading
Decent Holding Inc. Unveils US$8 Million Offering for Growth

Updated Category News Views 101

Decent Holding Inc. Announced Its New Offering In a significant move within the wastewater treatment sector, Decent Holding Inc. (NASDAQ: DXST) shared exciting news about their latest financing initiative. The company has introduced a registered offering amounting to US$8 million. This offering involves 13,333,333 Class A ordinary shares priced at US$0.60 each, along with...

Continue Reading
Nexxen Strengthens Data Strategies with Eric Solomon's Leadership

Updated Category News Views 208

Nexxen Appoints Eric Solomon to Drive Data Strategy In a significant move for the advertising technology landscape, Nexxen (NASDAQ: NEXN) has welcomed Eric Solomon as its new Senior Vice President for Product – Data. This appointment underscores Nexxen's dedication to a data-driven approach that aims to enhance growth and success for advertisers and media companies...

Continue Reading